GLAXOSMITHKLINE PLC

GSK

Delayed - 10/23 11:35:30 am
1343.8GBX	+0.48%

Prev.	1337.4000
Open	1333.2000
High	1354.6000
Low	1330.2000
Volume	5 895 669

1d ago	To Find a Coronavirus Vaccine, GlaxoSmithKline Is -2-
1d ago	To Find a Coronavirus Vaccine, GlaxoSmithKline Is Bonding With Its Biggest...
2d ago	Canada to invest up to C$214 mln for research into domestic-made vaccines -...
2d ago	GlaxoSmithKline : GSK - ViiV Healthcare presents continued positive findings...

	Short Term	Mid-Term	Long Term
Trend	Bearish	Bearish	Bearish
Resistance	1 416	1 533	1 575
Spread/Res.	-5,1%	-12%	-15%
Spread/Supp.	0,80%	0,80%	6,4%
Support	1 333	1 333	1 263

Sales 2020	34 651 M 45 128 M 45 128 M
Net income 2020	4 791 M 6 239 M 6 239 M
Net Debt 2020	22 730 M 29 602 M 29 602 M
P/E ratio 2020	13,9x
Yield 2020	5,95%

Capitalization	66 890 M 87 270 M 87 114 M
EV / Sales 2020	2,59x
EV / Sales 2021	2,46x
Nbr of Employees	99 437
Free-Float	91,3%

GlaxoSmithkline plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows:
- pharmaceutical products (52%): intended for respiratory diseases (67.5% of net sales), HIV infection (27.7%), immune system disorders (3.5%) ) and cancer (1,3%);
- OTC and...

>> Read more

Sector :

Pharmaceuticals - NEC

Calendar :

2020-10-28 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	OUTPERFORM
Number of Analysts	24
Average target price	1 806,25 GBX
Last Close Price	1 343,80 GBX
Spread / Highest target	74,9%
Spread / Average Target	34,4%
Spread / Lowest Target	-16,7%